Inventor · disambiguated record
Gregory D. Davis
Also filed as: DAVIS GREGORY · DAVIS GREGORY D
14 granted patents·20 pending applications·362 citations·filing 1990–2021
93Inventor score
Top patents by PatentIndex Score
34 records- 0198US10731181B2CRISPR-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2016·Granted Aug 4, 2020·45 cites·17 claims
- 0297US10745716B2CRISPR-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2016·Granted Aug 18, 2020·29 cites·22 claims
- 0393US8771985B2Genome editing of a Rosa locus using zinc-finger nucleasesCUI XIAOXIA·Filed 2011·Granted Jul 8, 2014·54 cites·20 claims
- 0493US5989868AFusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coliUNIV OKLAHOMA·Filed 1998·Granted Nov 23, 1999·129 cites·24 claims
- 0591US10604752B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2018·Granted Mar 31, 2020·6 cites·22 claims
- 0686US9512444B2Genome editing using targeting endonucleases and single-stranded nucleic acidsCHEN FUQIANG·Filed 2011·Granted Dec 6, 2016·14 cites·3 claims
- 0784US10767193B2Engineered CAS9 systems for eukaryotic genome modificationSIGMA ALDRICH CO LLC·Filed 2019·Granted Sep 8, 2020·3 cites·26 claims
- 0883US6383755B1Methods and kits for determining the fidelity of polymerase chain reaction conditionsCLONTECH LAB INC·Filed 2000·Granted May 7, 2002·14 cites·21 claims
- 0981US12065642B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2020·Granted Aug 20, 2024·1 cites·20 claims
- 1081US6207420B1Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in Escherichia coliUNIV OKLAHOMA·Filed 1999·Granted Mar 27, 2001·44 cites·24 claims
- 1179US2021388396A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2021·Application pending·0 cites
- 1276US2020140897A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2019·Application pending·0 cites
- 1375US2021207173A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2020·Application pending·0 cites
- 1475US2021079427A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2020·Application pending·0 cites
- 1574US2021207165A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2021·Application pending·0 cites
- 1673US2020002722A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2019·Application pending·0 cites
- 1767US2017191082A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2017·Application pending·0 cites
- 1866US12221606B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2020·Granted Feb 11, 2025·0 cites·13 claims
- 1966US2018135073A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2017·Application pending·0 cites
- 2065US2014273233A1Crispr-based genome modification and regulationCHEN FUQIANG·Filed 2014·Application pending·0 cites
- 2164US2014273230A1Crispr-based genome modification and regulationCHEN FUQIANG·Filed 2014·Application pending·0 cites
- 2263US2016017366A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2013·Application pending·0 cites
- 2361US2017073705A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2016·Application pending·0 cites
- 2459US12297449B2Engineered CAS9 systems for eukaryotic genome modificationSIGMA ALDRICH CO LLC·Filed 2020·Granted May 13, 2025·0 cites·33 claims
- 2557US2021180071A1Genome editing in bacteroidesSIGMA ALDRICH CO LLC·Filed 2020·Application pending·0 cites
- 2657US2021095273A1Modulation of microbiota compositions using targeted nucleasesSIGMA ALDRICH CO LLC·Filed 2020·Application pending·0 cites
- 2756US4980989ASignalling crab cageDAVIS GREGORY D·Filed 1990·Granted Jan 1, 1991·23 cites·8 claims
- 2854US2019271041A1Epigenetic modification of mammalian genomes using targeted endonucleasesSIGMA ALDRICH CO LLC·Filed 2019·Application pending·0 cites
- 2948US2019202856A1Engineered crispr proteins for covalent tagging nucleic acidsSIGMA ALDRICH CO LLC·Filed 2018·Application pending·0 cites
- 3047US11268144B2Methods and reagents for molecular proximity detection using RNA-guided nucleic acid binding proteinsSIGMA ALDRICH CO LLC·Filed 2016·Granted Mar 8, 2022·0 cites·3 claims
- 3143US2017051354A1Epigenetic modification of mammalian genomes using targeted endonucleasesSIGMA ALDRICH CO LLC·Filed 2015·Application pending·0 cites
- 3241US2019316102A1Modification of immune-related genomic loci using paired crispr nickase ribonucleoproteinsSIGMA ALDRICH CO LLC·Filed 2019·Application pending·0 cites
- 3334US2016376610A1Cell cycle dependent genome regulation and modificationSIGMA ALDRICH CO LLC·Filed 2016·Application pending·0 cites
- 3433US2011023156A1Feline genome editing with zinc finger nucleasesSIGMA ALDRICH CO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory D. Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →